Cargando…
Immunotherapy-related toxicity in lung cancer: clinical characteristics and managing strategy
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104203/ https://www.ncbi.nlm.nih.gov/pubmed/33410615 http://dx.doi.org/10.1097/CM9.0000000000001287 |
| _version_ | 1783689443636412416 |
|---|---|
| author | Luo, Wen-Xin Yang, Lan Li, Wei-Min |
| author_facet | Luo, Wen-Xin Yang, Lan Li, Wei-Min |
| author_sort | Luo, Wen-Xin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8104203 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81042032021-05-10 Immunotherapy-related toxicity in lung cancer: clinical characteristics and managing strategy Luo, Wen-Xin Yang, Lan Li, Wei-Min Chin Med J (Engl) Medical Progress Lippincott Williams & Wilkins 2021-04-05 2021-01-05 /pmc/articles/PMC8104203/ /pubmed/33410615 http://dx.doi.org/10.1097/CM9.0000000000001287 Text en Copyright © 2021 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
| spellingShingle | Medical Progress Luo, Wen-Xin Yang, Lan Li, Wei-Min Immunotherapy-related toxicity in lung cancer: clinical characteristics and managing strategy |
| title | Immunotherapy-related toxicity in lung cancer: clinical characteristics and managing strategy |
| title_full | Immunotherapy-related toxicity in lung cancer: clinical characteristics and managing strategy |
| title_fullStr | Immunotherapy-related toxicity in lung cancer: clinical characteristics and managing strategy |
| title_full_unstemmed | Immunotherapy-related toxicity in lung cancer: clinical characteristics and managing strategy |
| title_short | Immunotherapy-related toxicity in lung cancer: clinical characteristics and managing strategy |
| title_sort | immunotherapy-related toxicity in lung cancer: clinical characteristics and managing strategy |
| topic | Medical Progress |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104203/ https://www.ncbi.nlm.nih.gov/pubmed/33410615 http://dx.doi.org/10.1097/CM9.0000000000001287 |
| work_keys_str_mv | AT luowenxin immunotherapyrelatedtoxicityinlungcancerclinicalcharacteristicsandmanagingstrategy AT yanglan immunotherapyrelatedtoxicityinlungcancerclinicalcharacteristicsandmanagingstrategy AT liweimin immunotherapyrelatedtoxicityinlungcancerclinicalcharacteristicsandmanagingstrategy |